Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/ijms16022320 http://scihub22266oqcxt.onion/10.3390/ijms16022320 C4346839!4346839!25622251     free     free     free       Int+J+Mol+Sci 2015 ; 16 (2): 2320-51 Nephropedia Template TP {{tp|p=25622251|t=2015. Cyclic nucleotide signalling in kidney fibrosis |pdf=|usr=}}{{25622251}} gab.com Text Cyclic nucleotide signalling in kidney fibrosis JO: Int J Mol Sci http://www.kidney.de/pget.php?&tw=1&pmid=25622251 #FOAvip Kidney fibrosis is an important factor for the progression of kidney diseases, e.g., diabetes mellitus induced kidney failure, glomerulosclerosis and nephritis resulting in chronic kidney disease or end-stage renal disease. Cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) were implicated to suppress several of the above mentioned renal diseases. In this review article, identified effects and mechanisms of cGMP and cAMP regarding renal fibrosis are summarized. These mechanisms include several signalling pathways of nitric oxide/ANP/guanylyl cyclases/cGMP-dependent protein kinase and cAMP/Epac/adenylyl cyclases/cAMP-dependent protein kinase. Furthermore, diverse possible drugs activating these pathways are discussed. From these diverse mechanisms it is expected that new pharmacological treatments will evolve for the therapy or even prevention of kidney failure. Twit Text FOAVip Cyclic nucleotide signalling in kidney fibrosis ????Int J Mol Sci http://www.kidney.de/pget.php?&tw=1&pmid=25622251 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25622251 #FOAvip English Wikipedia <ref>{{Cite pmid|25622251}}</ref> Cyclic nucleotide signalling in kidney fibrosis #MMPMID25622251 Schinner E; Wetzl V; Schlossmann J Int J Mol Sci 2015[Feb]; 16 (2): 2320-51 PMID25622251show ga Kidney fibrosis is an important factor for the progression of kidney diseases, e.g., diabetes mellitus induced kidney failure, glomerulosclerosis and nephritis resulting in chronic kidney disease or end-stage renal disease. Cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) were implicated to suppress several of the above mentioned renal diseases. In this review article, identified effects and mechanisms of cGMP and cAMP regarding renal fibrosis are summarized. These mechanisms include several signalling pathways of nitric oxide/ANP/guanylyl cyclases/cGMP-dependent protein kinase and cAMP/Epac/adenylyl cyclases/cAMP-dependent protein kinase. Furthermore, diverse possible drugs activating these pathways are discussed. From these diverse mechanisms it is expected that new pharmacological treatments will evolve for the therapy or even prevention of kidney failure. äCyclic nucleotide signalling in kidney fibrosis (epmc).pdf DeepDyve Pubget Overpricing